Non-Amyloid-β Component of Human α-Synuclein Oligomers Induces Formation of New Aβ Oligomers: Insight into the Mechanisms That Link Parkinson's and Alzheimer's Diseases

ACS Chemical Neuroscience

Volumn 7, Issue 1, 2016, Pages 46-55

  Atsmon Raz, Yoav ^a   Miller, Yifat ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Alzheimer's disease; amyloid , synuclein; amyloids; cross seeding; NAC; Parkinson's disease; peptides; self assembly

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN[1-42]; OLIGOMER; AMYLOID; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT; SNCA PROTEIN, HUMAN;

ALZHEIMER DISEASE; ARTICLE; DISEASE ASSOCIATION; HUMAN; HYDROPHOBICITY; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN POLYMORPHISM; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; STATIC ELECTRICITY; CHEMICAL PHENOMENA; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; NONLINEAR SYSTEM;

ALPHA-SYNUCLEIN; ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PEPTIDES; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MOLECULAR DYNAMICS SIMULATION; MOLECULAR STRUCTURE; NONLINEAR DYNAMICS; PARKINSON DISEASE; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION;

EID: 84955600572     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/acschemneuro.5b00204     Document Type: Article

References (81)

1. Forman, M. S., Schmidt, M. L., Kasturi, S., Perl, D. P., Lee, V. M., and Trojanowski, J. Q. (2002) Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam Am. J. Pathol. 160 (5) 1725-31 10.1016/S0002-9440(10)61119-4
2. Lippa, C. F., Fujiwara, H., Mann, D. M., Giasson, B., Baba, M., Schmidt, M. L., Nee, L. E., O'Connell, B., Pollen, D. A., St. George-Hyslop, P., Ghetti, B., Nochlin, D., Bird, T. D., Cairns, N. J., Lee, V. M., Iwatsubo, T., and Trojanowski, J. Q. (1998) Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes Am. J. Pathol. 153 (5) 1365-70 10.1016/S0002-9440(10)65722-7
3. Lippa, C. F., Schmidt, M. L., Lee, V. M., and Trojanowski, J. Q. (1999) Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease Ann. Neurol. 45 (3) 353-7 10.1002/1531-8249(199903)45:3<353::AID-ANA11>3.0.CO;2-4
4. Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., and Roses, A. D. (1993) Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 90 (20) 9649-9653 10.1073/pnas.90.20.9649
5. Walsh, D., Klyubin, I., Fadeeva, J., Rowan, M., and Selkoe, D. (2002) Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition Biochem. Soc. Trans. 30 (4) 552-557 10.1042/bst0300552
6. Hurtig, H. I., Trojanowski, J. Q., Galvin, J., Ewbank, D., Schmidt, M. L., Lee, V. M., Clark, C. M., Glosser, G., Stern, M. B., Gollomp, S. M., and Arnold, S. E. (2000) Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease Neurology 54 (10) 1916-21 10.1212/WNL.54.10.1916
7. Leverenz, J. B., Quinn, J. F., Zabetian, C., Zhang, J., Montine, K. S., and Montine, T. J. (2009) Cognitive impairment and dementia in patients with Parkinson disease Curr. Top. Med. Chem. 9 (10) 903-12
8. Moussaud, S., Jones, D. R., Moussaud-Lamodiere, E. L., Delenclos, M., Ross, O. A., and McLean, P. J. (2014) Alpha-synuclein and tau: teammates in neurodegeneration? Mol. Neurodegener. 9, 43 10.1186/1750-1326-9-43
9. Hamilton, R. L. (2000) Lewy Bodies in Alzheimer's Disease: A Neuropathological Review of 145 Cases Using α-Synuclein Immunohistochemistry Brain Pathol. 10 (3) 378-384 10.1111/j.1750-3639.2000.tb00269.x
10. Ballatore, C., Lee, V. M., and Trojanowski, J. Q. (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders Nat. Rev. Neurosci. 8 (9) 663-72 10.1038/nrn2194
11. Galpern, W. R. and Lang, A. E. (2006) Interface between tauopathies and synucleinopathies: A tale of two proteins Ann. Neurol. 59 (3) 449 10.1002/ana.20819
12. Mandal, P. K., Pettegrew, J. W., Masliah, E., Hamilton, R. L., and Mandal, R. (2006) Interaction between Aβ peptide and α synuclein: molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body disease Neurochem. Res. 31 (9) 1153-1162 10.1007/s11064-006-9140-9
13. Aarsland, D., Zaccai, J., and Brayne, C. (2005) A systematic review of prevalence studies of dementia in Parkinson's disease Mov. Disord. 20 (10) 1255-63 10.1002/mds.20527
14. Braak, H., Rub, U., Jansen Steur, E. N., Del Tredici, K., and de Vos, R. A. (2005) Cognitive status correlates with neuropathologic stage in Parkinson disease Neurology 64 (8) 1404-10 10.1212/01.WNL.0000158422.41380.82
15. Leverenz, J. B., Fishel, M. A., Peskind, E. R., Montine, T. J., Nochlin, D., Steinbart, E., Raskind, M. A., Schellenberg, G. D., Bird, T. D., and Tsuang, D. (2006) Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype Arch. Neurol. 63 (3) 370-6 10.1001/archneur.63.3.370
16. Leverenz, J. B., Hamilton, R., Tsuang, D. W., Schantz, A., Vavrek, D., Larson, E. B., Kukull, W. A., Lopez, O., Galasko, D., Masliah, E., Kaye, J., Woltjer, R., Clark, C., Trojanowski, J. Q., and Montine, T. J. (2008) Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient Brain Pathol. 18 (2) 220-4 10.1111/j.1750-3639.2007.00117.x
17. Masliah, E., Rockenstein, E., Veinbergs, I., Sagara, Y., Mallory, M., Hashimoto, M., and Mucke, L. (2001) beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease Proc. Natl. Acad. Sci. U. S. A. 98 (21) 12245-50 10.1073/pnas.211412398
18. Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., and Goedert, M. (1998) α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies Proc. Natl. Acad. Sci. U. S. A. 95 (11) 6469-6473 10.1073/pnas.95.11.6469
19. Jensen, P. H., Hojrup, P., Hager, H., Nielsen, M. S., Jacobsen, L., Olesen, O. F., Gliemann, J., and Jakes, R. (1997) Binding of Abeta to alpha- and beta-synucleins: identification of segments in alpha-synuclein/NAC precursor that bind Abeta and NAC Biochem. J. 323 (2) 539-546 10.1042/bj3230539
20. Jose, J. C., Chatterjee, P., and Sengupta, N. (2014) Cross dimerization of amyloid-beta and alphasynuclein proteins in aqueous environment: a molecular dynamics simulations study PLoS One 9 (9) e106883 10.1371/journal.pone.0106883
21. Selkoe, D. J. (2001) Alzheimer's disease: genes, proteins, and therapy Physiol. Rev. 81 (2) 741-66
22. Lansbury, P. T. and Lashuel, H. A. (2006) A century-old debate on protein aggregation and neurodegeneration enters the clinic Nature 443 (7113) 774-9 10.1038/nature05290
23. Jarrett, J. T., Berger, E. P., and Lansbury, P. T., Jr. (1993) The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease Biochemistry 32 (18) 4693-7 10.1021/bi00069a001
24. Roher, A. E., Lowenson, J. D., Clarke, S., Wolkow, C., Wang, R., Cotter, R. J., Reardon, I. M., Zurcher-Neely, H. A., Heinrikson, R. L., and Ball, M. J. 1993, Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease J. Biol. Chem. 268 (5) 3072-83
25. Roher, A. E., Lowenson, J. D., Clarke, S., Woods, A. S., Cotter, R. J., Gowing, E., and Ball, M. J. (1993) beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 90 (22) 10836-40 10.1073/pnas.90.22.10836
26. Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., and Goedert, M. (1998) alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies Proc. Natl. Acad. Sci. U. S. A. 95 (11) 6469-73 10.1073/pnas.95.11.6469
27. Conway, K. A., Lee, S. J., Rochet, J. C., Ding, T. T., Williamson, R. E., and Lansbury, P. T., Jr. (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy Proc. Natl. Acad. Sci. U. S. A. 97 (2) 571-6 10.1073/pnas.97.2.571
28. Goldberg, M. S. and Lansbury, P. T., Jr. (2000) Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease? Nat. Cell Biol. 2 (7) E115-9 10.1038/35017124
29. Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., and Mucke, L. (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders Science 287 (5456) 1265-9 10.1126/science.287.5456.1265
30. Sipe, J. D. and Cohen, A. S. (2000) Review: history of the amyloid fibril J. Struct. Biol. 130 (2-3) 88-98 10.1006/jsbi.2000.4221
31. Overk, C. R. and Masliah, E. (2014) Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease Biochem. Pharmacol. 88 (4) 508-16 10.1016/j.bcp.2014.01.015
32. Dahlgren, K. N., Manelli, A. M., Stine, W. B., Jr., Baker, L. K., Krafft, G. A., and LaDu, M. J. (2002) Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability J. Biol. Chem. 277 (35) 32046-53 10.1074/jbc.M201750200
33. Zhang, Y., McLaughlin, R., Goodyer, C., and LeBlanc, A. (2002) Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons J. Cell Biol. 156 (3) 519-29 10.1083/jcb.200110119
34. Burre, J., Sharma, M., and Sudhof, T. C. (2015) Definition of a molecular pathway mediating alpha-synuclein neurotoxicity J. Neurosci. 35 (13) 5221-32 10.1523/JNEUROSCI.4650-14.2015
35. Morales, R., Moreno-Gonzalez, I., and Soto, C. (2013) Cross-seeding of misfolded proteins: implications for etiology and pathogenesis of protein misfolding diseases PLoS Pathog. 9 (9) e1003537 10.1371/journal.ppat.1003537
36. Miller, Y., Ma, B., and Nussinov, R. (2011) Synergistic interactions between repeats in tau protein and Abeta amyloids may be responsible for accelerated aggregation via polymorphic states Biochemistry 50 (23) 5172-81 10.1021/bi200400u
37. Raz, Y. and Miller, Y. (2013) Interactions between Abeta and mutated Tau lead to polymorphism and induce aggregation of Abeta-mutated tau oligomeric complexes PLoS One 8 (8) e73303 10.1371/journal.pone.0073303
38. Berhanu, W. M., Yasar, F., and Hansmann, U. H. (2013) In silico cross seeding of Abeta and amylin fibril-like oligomers ACS Chem. Neurosci. 4 (11) 1488-500 10.1021/cn400141x
39. Luhrs, T., Ritter, C., Adrian, M., Riek-Loher, D., Bohrmann, B., Dobeli, H., Schubert, D., and Riek, R. (2005) 3D structure of Alzheimer's amyloid-beta(1-42) fibrils Proc. Natl. Acad. Sci. U. S. A. 102 (48) 17342-7 10.1073/pnas.0506723102
40. Petkova, A. T., Ishii, Y., Balbach, J. J., Antzutkin, O. N., Leapman, R. D., Delaglio, F., and Tycko, R. (2002) A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR Proc. Natl. Acad. Sci. U. S. A. 99 (26) 16742-7 10.1073/pnas.262663499
41. Atsmon-Raz, Y. and Miller, Y. (2015) A Proposed Atomic Structure of the Self-Assembly of the Non-Amyloid-beta Component of Human alpha-Synuclein As Derived by Computational Tools J. Phys. Chem. B 119 (31) 10005-15 10.1021/acs.jpcb.5b03760
42. Masel, J., Jansen, V. A., and Nowak, M. A. (1999) Quantifying the kinetic parameters of prion replication Biophys. Chem. 77 (2-3) 139-52 10.1016/S0301-4622(99)00016-2
43. Stamm, M., Staritzbichler, R., Khafizov, K., and Forrest, L. R. (2014) AlignMe - a membrane protein sequence alignment web server Nucleic Acids Res. 42, W246-51 10.1093/nar/gku291
44. Stamm, M., Staritzbichler, R., Khafizov, K., and Forrest, L. R. (2013) Alignment of helical membrane protein sequences using AlignMe PLoS One 8 (3) e57731 10.1371/journal.pone.0057731
45. Khafizov, K., Staritzbichler, R., Stamm, M., and Forrest, L. R. (2010) A study of the evolution of inverted-topology repeats from LeuT-fold transporters using AlignMe Biochemistry 49 (50) 10702-13 10.1021/bi101256x
46. Lee, M. S., Feig, M., Salsbury, F. R., Jr., and Brooks, C. L., 3rd (2003) New analytic approximation to the standard molecular volume definition and its application to generalized Born calculations J. Comput. Chem. 24 (11) 1348-56 10.1002/jcc.10272
47. Lee, M. S., Salsbury, F. R., and Brooks, C. L. (2002) Novel generalized Born methods J. Chem. Phys. 116 (24) 10606 10.1063/1.1480013
48. Miller, Y., Ma, B., and Nussinov, R. (2011) The unique Alzheimer's beta-amyloid triangular fibril has a cavity along the fibril axis under physiological conditions J. Am. Chem. Soc. 133 (8) 2742-8 10.1021/ja1100273
49. Miller, Y., Ma, B., and Nussinov, R. (2010) Polymorphism in Alzheimer Abeta amyloid organization reflects conformational selection in a rugged energy landscape Chem. Rev. 110 (8) 4820-38 10.1021/cr900377t
50. Wineman-Fisher, V., Atsmon-Raz, Y., and Miller, Y. (2015) Orientations of residues along the beta-arch of self-assembled amylin fibril-like structures lead to polymorphism Biomacromolecules 16 (1) 156-65 10.1021/bm501326y
51. Krieger, F., Moglich, A., and Kiefhaber, T. (2005) Effect of proline and glycine residues on dynamics and barriers of loop formation in polypeptide chains J. Am. Chem. Soc. 127 (10) 3346-52 10.1021/ja042798i
52. Steinert, P. M., Mack, J. W., Korge, B. P., Gan, S. Q., Haynes, S. R., and Steven, A. C. (1991) Glycine loops in proteins: their occurrence in certain intermediate filament chains, loricrins and single-stranded RNA binding proteins Int. J. Biol. Macromol. 13 (3) 130-9 10.1016/0141-8130(91)90037-U
53. Baram, M., Atsmon-Raz, Y., Ma, B., Nussinov, R., and Miller, Y. (2015) Amylin-Abeta oligomers at atomic resolution using molecular dynamics simulations: a link between Type 2 diabetes and Alzheimer's disease Phys. Chem. Chem. Phys. 10.1039/C5CP03338A
54. Yamazaki, T., Blinov, N., Wishart, D., and Kovalenko, A. (2008) Hydration effects on the HET-s prion and amyloid-beta fibrillous aggregates, studied with three-dimensional molecular theory of solvation Biophys. J. 95 (10) 4540-8 10.1529/biophysj.107.123000
55. Massi, F. and Straub, J. E. (2003) Structural and dynamical analysis of the hydration of the Alzheimer's beta-amyloid peptide J. Comput. Chem. 24 (2) 143-53 10.1002/jcc.10101
56. Ma, B. and Nussinov, R. (2006) Simulations as analytical tools to understand protein aggregation and predict amyloid conformation Curr. Opin. Chem. Biol. 10 (5) 445-52 10.1016/j.cbpa.2006.08.018
57. Clinton, L. K., Blurton-Jones, M., Myczek, K., Trojanowski, J. Q., and LaFerla, F. M. (2010) Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline J. Neurosci. 30 (21) 7281-9 10.1523/JNEUROSCI.0490-10.2010
58. Tsigelny, I. F., Crews, L., Desplats, P., Shaked, G. M., Sharikov, Y., Mizuno, H., Spencer, B., Rockenstein, E., Trejo, M., Platoshyn, O., Yuan, J. X., and Masliah, E. (2008) Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases PLoS One 3 (9) e3135 10.1371/journal.pone.0003135
59. Ono, K., Takahashi, R., Ikeda, T., and Yamada, M. (2012) Cross-seeding effects of amyloid beta-protein and alpha-synuclein J. Neurochem. 122 (5) 883-90 10.1111/j.1471-4159.2012.07847.x
60. Atwood, C. S., Obrenovich, M. E., Liu, T., Chan, H., Perry, G., Smith, M. A., and Martins, R. N. (2003) Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta Brain Res. Rev. 43 (1) 1-16 10.1016/S0165-0173(03)00174-7
61. Giuffrida, M. L., Caraci, F., Pignataro, B., Cataldo, S., De Bona, P., Bruno, V., Molinaro, G., Pappalardo, G., Messina, A., Palmigiano, A., Garozzo, D., Nicoletti, F., Rizzarelli, E., and Copani, A. (2009) Beta-amyloid monomers are neuroprotective J. Neurosci. 29 (34) 10582-7 10.1523/JNEUROSCI.1736-09.2009
62. Bonini, N. M. and Giasson, B. I. (2005) Snaring the function of alpha-synuclein Cell 123 (3) 359-61 10.1016/j.cell.2005.10.017
63. Vilar, M., Chou, H. T., Luhrs, T., Maji, S. K., Riek-Loher, D., Verel, R., Manning, G., Stahlberg, H., and Riek, R. (2008) The fold of alpha-synuclein fibrils Proc. Natl. Acad. Sci. U. S. A. 105 (25) 8637-42 10.1073/pnas.0712179105
64. Heise, H., Hoyer, W., Becker, S., Andronesi, O. C., Riedel, D., and Baldus, M. (2005) Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR Proc. Natl. Acad. Sci. U. S. A. 102 (44) 15871-6 10.1073/pnas.0506109102
65. Bubeck, D. (2015) Unraveling structural polymorphism of amyloid fibers Structure 23 (1) 10-1 10.1016/j.str.2014.12.005
66. Mukrasch, M. D., Bibow, S., Korukottu, J., Jeganathan, S., Biernat, J., Griesinger, C., Mandelkow, E., and Zweckstetter, M. (2009) Structural polymorphism of 441-residue tau at single residue resolution PLoS Biol. 7 (2) e34 10.1371/journal.pbio.1000034
67. Miller, Y., Ma, B., and Nussinov, R. (2009) Polymorphism of Alzheimer's Abeta17-42 (p3) oligomers: the importance of the turn location and its conformation Biophys. J. 97 (4) 1168-77 10.1016/j.bpj.2009.05.042
68. Hard, T. (2014) Amyloid Fibrils: Formation, Polymorphism, and Inhibition J. Phys. Chem. Lett. 5 (3) 607-14 10.1021/jz4027612
69. Yu, X., Luo, Y., Dinkel, P., Zheng, J., Wei, G., Margittai, M., Nussinov, R., and Ma, B. (2012) Cross-seeding and conformational selection between three-and four-repeat human Tau proteins J. Biol. Chem. 287 (18) 14950-14959 10.1074/jbc.M112.340794
70. Xiao, Y., Ma, B., McElheny, D., Parthasarathy, S., Long, F., Hoshi, M., Nussinov, R., and Ishii, Y. (2015) A[beta](1-42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer's disease Nat. Struct. Mol. Biol. 22 (6) 499-505 10.1038/nsmb.2991
71. Kalé, L., Skeel, R., Bhandarkar, M., Brunner, R., Gursoy, A., Krawetz, N., Phillips, J., Shinozaki, A., Varadarajan, K., and Schulten, K. (1999) NAMD2: Greater Scalability for Parallel Molecular Dynamics J. Comput. Phys. 151 (1) 283 10.1006/jcph.1999.6201
72. MacKerell, A. D., Bashford, D., Bellott, M., Dunbrack, R. L., Evanseck, J. D., Field, M. J., Fischer, S., Gao, J., Guo, H., Ha, S., Joseph-McCarthy, D., Kuchnir, L., Kuczera, K., Lau, F. T., Mattos, C., Michnick, S., Ngo, T., Nguyen, D. T., Prodhom, B., Reiher, W. E., Roux, B., Schlenkrich, M., Smith, J. C., Stote, R., Straub, J., Watanabe, M., Wiorkiewicz-Kuczera, J., Yin, D., and Karplus, M. (1998) All-atom empirical potential for molecular modeling and dynamics studies of proteins J. Phys. Chem. B 102 (18) 3586-616 10.1021/jp973084f
73. Brooks, B. R., Bruccoleri, R. E., Olafson, B. D., States, D. J., Swaminathan, S., and Karplus, M. (1983) CHARMM: A program for macromolecular energy, minimization, and dynamics calculations J. Comput. Chem. 4 (2) 187-217 10.1002/jcc.540040211
74. Mahoney, M. W. and Jorgensen, W. L. (2000) A five-site model for liquid water and the reproduction of the density anomaly by rigid, nonpolarizable potential functions J. Chem. Phys. 112 (20) 8910 10.1063/1.481505
75. Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., and Klein, M. L. (1983) Comparison of simple potential functions for simulating liquid water J. Chem. Phys. 79 (2) 926 10.1063/1.445869
76. Tu, K., Tobias, D. J., and Klein, M. L. (1995) Constant pressure and temperature molecular dynamics simulation of a fully hydrated liquid crystal phase dipalmitoylphosphatidylcholine bilayer Biophys. J. 69 (6) 2558-62 10.1016/S0006-3495(95)80126-8
77. Feller, S. E., Zhang, Y., Pastor, R. W., and Brooks, B. R. (1995) Constant pressure molecular dynamics simulation: The Langevin piston method J. Chem. Phys. 103 (11) 4613 10.1063/1.470648
78. Darden, T., York, D., and Pedersen, L. (1993) Particle mesh Ewald: An N [center-dot] log(N) method for Ewald sums in large systems J. Chem. Phys. 98 (12) 10089-10092 10.1063/1.464397
79. Essmann, U., Perera, L., Berkowitz, M. L., Darden, T., Lee, H., and Pedersen, L. G. (1995) A smooth particle mesh Ewald method J. Chem. Phys. 103 (19) 8577 10.1063/1.470117
80. Ryckaert, J.-P., Ciccotti, G., and Berendsen, H. J. C. (1977) Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes J. Comput. Phys. 23 (3) 327 10.1016/0021-9991(77)90098-5
81. Akesson, B., Panagiotidis, G., Westermark, P., and Lundquist, I. (2003) Islet amyloid polypeptide inhibits glucagon release and exerts a dual action on insulin release from isolated islets Regul. Pept. 111 (1-3) 55-60 10.1016/S0167-0115(02)00252-5